|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01877 JUNSHI BIO
Nominal 
12.020 +0.040 (+0.334%) | 2024/06 - Interim RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | (2,014,964) | (1,775,325) | (641,901) | (1,498,806) |
| Net Cash from / (used in) Investing Activities | -- | (892,422) | (467,619) | (1,880,952) | (697,976) |
| Net Cash from / (used in) Financing Activities | -- | 681,041 | 4,643,009 | 2,665,686 | 4,413,522 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | (2,226,345) | 2,400,065 | 142,833 | 2,216,740 |
| Cash & Cash Equivalents at beginning of period | -- | 5,996,936 | 3,504,605 | 3,384,998 | 1,214,026 |
| Effect of Foreign Exchange Rate Changes | -- | 7,551 | 92,266 | (23,226) | (45,768) |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 3,778,142 | 5,996,936 | 3,504,605 | 3,384,998 |
| Remarks: | Real time quote last updated: 24/12/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -645,691,000 |
| %Change | -35.199% |
| EPS / (LPS) | RMB -0.660 |
| NBV Per Share (¥) | RMB 6.591 |